@incollection{, 42410D54E242A07F11D32F1E7FAC5D4E , author={{Yong-FeiLiu} and {JuanSu} and {Wei-JianJiang} and {Third Military Medical University}}, journal={{Global Journal of Medical Research}}, journal={{GJMR}}2249-46180975-588810.34257/GJMR, address={Cambridge, United States}, publisher={Global Journals Organisation}1611120 } @incollection{b0, , title={{Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council}} , author={{ JBBederson } and { EJConnolly } and { HHBatjer } and { RGDacey } and { JEDion } and { MNDiringer }} , journal={{American Heart Association. Stroke}} 40 , year={2009} } @incollection{b1, , title={{Time trends in outcome of subarachnoid hemorrhage: Populationbased study and systematic review}} , author={{ CELovelock } and { GJRinkel } and { PMRothwell }} , journal={{Neurology}} 74 , year={2010} } @incollection{b2, , title={{Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms: Report on 69 cases}} , author={{ YMurayama } and { TMalisch } and { GGuglielmi } and { MEMawad } and { FVinuela } and { GRDuckwiler }} , journal={{J Neurosurg}} 87 , year={1997} } @incollection{b3, , title={{Frequency of cerebral vasospasm in patients treated with endovascular occlusion of intracranial aneurysms}} , author={{ KYalamanchili } and { RHRosenwasser } and { JEThomas } and { KLiebman } and { CMcmorrow } and { PGannon }} , journal={{AJNR Am J Neuroradiol}} 19 , year={1998} } @incollection{b4, , title={{Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage}} , author={{ CCharpentier } and { GAudibert } and { FGuillemin } and { TCivit } and { XDucrocq } and { SBracard }} , journal={{Stroke}} 30 , year={1999} } @incollection{b5, , title={{Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage}} , author={{ SGKeyrouz } and { MNDiringer }} , journal={{Crit Care}} 11 220 , year={2007} } @incollection{b6, , title={{Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage}} , author={{ DCastanares-Zapatero } and { PHantson }} , journal={{ANNALS OF INTENSIVE CARE}} 1 , year={2011} } @incollection{b7, , title={{Vasospasm after aneurysmal subarachnoid hemorrhage: Review of randomized controlled trials and meta-analyses in the literature}} , author={{ GJVelat } and { MMKimball } and { JDMocco } and { BLHoh }} , journal={{World Neurosurg}} 76 , year={2011} } @incollection{b8, , title={{Treatment of subarachnoid hemorrhage}} , author={{ AKRaya } and { MNDiringer }} , journal={{Crit Care Clin}} 30 , year={2014} } @incollection{b9, , title={{Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage}} , author={{ AARabinstein } and { GLanzino } and { EFWijdicks }} , journal={{Lancet Neurol}} 9 , year={2010} } @incollection{b10, , title={{Incidence of and factors associated with manipulation of nimodipine dosage in patients with aneurysmal subarachnoid hemorrhage}} , author={{ MMackenzie } and { SKGorman } and { SDoucette } and { RGreen }} , journal={{Can J Hosp Pharm}} 67 , year={2014} } @incollection{b11, , title={{Local delivery of nimodipine by Prolonged-Release microparticles-feasibility, effectiveness and Dose-Finding in experimental subarachnoid hemorrhage}} , author={{ DHänggi } and { JPerrin } and { SEicker } and { KBeseoglu } and { NEtminan } and { MAKamp }} , journal={{PLoS ONE}} 7 e42597 , year={2012} } @incollection{b12, , title={{Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage}} , author={{ SOtt } and { SJedlicka } and { SWolf } and { MPeter } and { CPudenz } and { PMerker }} , journal={{Biomed Res Int}} 970741 , year={2014. 2014} } @incollection{b13, , title={{Nimodipine in aneurysmal subarachnoid hemorrhage: A randomized study of intravenous or peroral administration}} , author={{ EKronvall } and { PUndren } and { BRomner } and { HSaveland } and { MCronqvist } and { OGNilsson }} , journal={{J Neurosurg}} 110 , year={2009} } @incollection{b14, , title={{Comparison of nimodipine delivery routes in cerebral vasospasm after subarachnoid hemorrhage: An experimental study in rabbits}} , author={{ MBOnal } and { ECivelek } and { AKircelli } and { ISolmaz } and { SUgurel } and { FNarin }} , journal={{Acta Neurochir Suppl}} 110 , year={2011} } @incollection{b15, , title={{Effects of Topical Administration of Nimodipine on Cerebral Blood Flow following Subarachnoid Hemorrhage in Pigs}} , author={{ FWang } and { YYin } and { FJia } and { JJiang }} , journal={{Journal of Neurotrauma}} 30 , year={2013} } @incollection{b16, , title={{Endovascular treatment of cerebral vasospasm: Transluminal balloon angioplasty, intra-arterial papaverine, and intraarterial nicardipine}} , author={{ BLHoh } and { CSOgilvy }} , journal={{Neurosurg Clin N Am}} 16 , year={2005} } @incollection{b17, , title={{Nicardipine in the treatment of aneurysmal subarachnoid haemorrhage: A meta-analysis of published data}} , author={{ RHuang } and { FJiang } and { ZFeng } and { TWang }} , journal={{Acta Neurologica Belgica}} 113 , year={2013} } @incollection{b18, , title={{Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage}} , author={{ PJun } and { NUKo } and { JDEnglish } and { CFDowd } and { VVHalbach } and { RTHigashida }} , journal={{AJNR Am J Neuroradiol}} 31 , year={2010} } @incollection{b19, , title={{High-dose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachnoid hemorrhage: Prolonged effects on hemodynamic parameters and brain metabolism}} , author={{ RMStuart } and { RHelbok } and { PKurtz } and { MSchmidt } and { LFernandez } and { KLee }} , journal={{Neurosurgery}} 68 , year={2011} } @incollection{b20, , title={{Hemodynamic stability after intraarterial injection of verapamil for cerebral vasospasm}} , author={{ AMFlexman } and { CJRyerson } and { POTalke }} , journal={{Anesthesia & Analgesia}} 114 , year={2012} } @book{b21, , title={{Intra-arterial injection of verapamil in treatment of cerebral vasospasm in a patient with acute subarachnoid hemorrhage from an aneurysm: Case report}} , author={{ KGMikeladze } and { SEliava } and { ODShekhtman } and { ALubnin } and { TFTabasaranskii } and { SBIakovlev }} , year={2013} 77 60 Zh Vopr Neirokhir Im N N Burdenko } @incollection{b22, , title={{High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage}} , author={{ JKeuskamp } and { RMurali } and { KHChao }} , journal={{J Neurosurg}} 108 , year={2008} } @incollection{b23, , title={{Novel treatments for vasospasm after subarachnoid hemorrhage}} , author={{ CMuroi } and { MSeule } and { KMishima } and { EKeller }} , journal={{Current Opinion in Critical Care}} 18 , year={2012} } @incollection{b24, , title={{Iatrogenic vasospasm in carotid artery stent angioplasty with distal protection devices}} , author={{ CMSchirmer } and { DAHoit } and { AMMalek }} , journal={{Neurosurg Focus}} 24 E12 , year={2008} } @incollection{b25, , title={{Clinical investigation of fasudil for the prevention of cerebral vasospasm in extracranial carotid artery stenting}} , author={{ JLiu } and { GYao } and { HZhou } and { XJiang } and { PXie }} , journal={{Cell Biochemistry and Biophysics}} 68 , year={2014} } @incollection{b26, , title={{Antivasospastic effects of hydroxyfasudil, a Rho-Kinase inhibitor, after subarachnoid hemorrhage}} , author={{ SSatoh } and { MTakayasu } and { KKawasaki } and { IIkegaki } and { AHitomi } and { KYano }} , journal={{Journal of Pharmacological Sciences}} 118 , year={2012} } @incollection{b27, , title={{Suppression of the Rho/Rho-kinase pathway and prevention of cerebral vasospasm by combination treatment with statin and fasudil after subarachnoid hemorrhage in rabbit}} , author={{ MNaraoka } and { AMunakata } and { NMatsuda } and { NShimamura } and { HOhkuma }} , journal={{Transl Stroke Res}} 4 , year={2013} } @incollection{b28, , title={{Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage}} , author={{ GJLiu } and { ZJWang } and { YFWang } and { LLXu } and { XLWang } and { YLiu }} , journal={{European Journal of Clinical Pharmacology}} 68 , year={2012} } @incollection{b29, , title={{Cerebral autoregulation is influenced by carbon dioxide levels in patients with septic shock}} , author={{ FSTaccone } and { DCastanares-Zapatero } and { DPeres-Bota } and { JLVincent } and { ' JBerre } and { CMelot }} , journal={{Neurocrit Care}} 12 , year={2010} } @incollection{b30, , title={{Potentials of magnesium treatment in subarachnoid haemorrhage}} , author={{ WMVan Den Bergh } and { RMDijkhuizen } and { GJRinkel }} , journal={{Magnes Res}} 17 , year={2004} } @incollection{b31, , title={{Is the magnesium era for aneurysmal subarachnoid hemorrhage over?}} , author={{ SOrtega-Gutierrez } and { SAMayer }} , journal={{Curr Neurol Neurosci Rep}} 10 , year={2010} } @incollection{b32, , title={{Critical care management of patients following aneurysmal subarachnoid hemorrhage: Recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference}} , author={{ MNDiringer } and { TPBleck } and { HjrClaude } and { DMenon } and { LShutter } and { PVespa }} , journal={{Neurocrit Care}} 15 , year={2011} } @incollection{b33, , title={{Magnesium sulfate in aneurysmal subarachnoid hemorrhage: A randomized controlled trial}} , author={{ WMVan Den Bergh } and { AAlgra } and { FVan Kooten } and { CMDirven } and { JVan Gijn } and { MVermeulen }} , journal={{Stroke}} 36 , year={2005} } @incollection{b34, , title={{Prophylactic magnesium for improving neurologic outcome after aneurysmal subarachnoid hemorrhage: Systematic review and meta-analysis}} , author={{ EGolan } and { DNVasquez } and { NDFerguson } and { NkjAdhikari } and { DCScales }} , journal={{Journal of Critical Care}} 28 , year={2013} } @incollection{b35, , title={{A randomised controlled trial of induced hypermagnesaemia following aneurysmal subarachnoid haemorrhage}} , author={{ CMBradford } and { SFinfer } and { O'Connor } and { AYarad } and { EFirth } and { RMccallister } and { R }} , journal={{Crit Care Resusc}} 15 , year={2013} } @incollection{b36, , title={{Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurismal subarachnoid hemorrhages: a randomized controlled trial}} , author={{ TYamamoto } and { KMori } and { TEsaki } and { YNakao } and { JTokugawa } and { MWatanabe }} , journal={{J Neurosurg}} 31 , year={2015} } @incollection{b37, , title={{Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme a reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity}} , author={{ AEndo } and { MKuroda } and { KTanzawa }} , journal={{FEBS Lett}} 72 , year={1976} } @incollection{b38, , title={{Unresolved issues in the management of aneurysmal subarachnoid hemorrhage}} , author={{ CBautista }} , journal={{AACN Advanced Critical Care}} 23 , year={2012} } @incollection{b39, , title={{Endothelial nitric oxide synthasedependent cerebral blood flow augmentation by Larginine after chronic statin treatment}} , author={{ MYamada } and { ZHuang } and { TDalkara } and { MEndres } and { ULaufs } and { CWaeber }} , journal={{J Cereb Blood Flow Metab}} 20 , year={2000} } @incollection{b40, , title={{Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis update}} , author={{ MDVergouwen } and { RJDe Haan } and { MVermeulen } and { YBRoos }} , journal={{Stroke}} 41 , year={2010} } @incollection{b41, , title={{Role of simvastatin in prevention of vasospasm and improving functional outcome after aneurysmal sub-arachnoid hemorrhage: A prospective, randomized, double-blind, placebocontrolled pilot trial}} , author={{ KGarg } and { SSinha } and { SSKale } and { PSChandra } and { ASuri } and { MMSingh }} , journal={{Br J Neurosurg}} 27 , year={2013} } @incollection{b42, , title={{Effects of statinsuse for patients with aneurysmal subarachnoid after aneurysmal subarachnoid hemorrhage}} , author={{ SHSu } and { WXu } and { JHai } and { YFWu } and { FYu }} , journal={{Transl Stroke Res}} 5 , year={2014} } @incollection{b43, , title={{Cerebral vasospasm pharmacological treatment: An update}} , author={{ ISiasios } and { EZKapsalaki } and { KNFountas }} , journal={{Neurology Research International}} 2013 , year={2013} } @incollection{b44, , title={{Cerebrovascular characterization of clazosentan, the first nonpeptide endothelin receptor antagonist clinically effective for the treatment of cerebral vasospasm. Part I: Inhibitory effect on endothelin(A) receptor-mediated contraction}} , author={{ HVatter } and { MZimmermann } and { VTesanovic } and { ARaabe } and { LSchilling } and { VSeifert }} , journal={{J Neurosurg}} 102 , year={2005} } @incollection{b45, , title={{MEK1/2 inhibitor U0126 but not endothelin receptor antagonist clazosentan reduces upregulation of cerebrovascular contractile receptors and delayed cerebral ischemia, and improves outcome after subarachnoid hemorrhage in rats}} , author={{ GKPovlsen } and { LEdvinsson }} , journal={{J Cereb Blood Flow Metab}} 35 , year={2015} } @incollection{b46, , title={{Effect of clazosentan in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials}} , author={{ XWang } and { YMLi } and { WQLi } and { CGHuang } and { YCLu } and { LJHou }} , journal={{PLoS One}} 7 e47778 , year={2012} } @incollection{b47, , title={{Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: A metaanalysis of randomized controlled trials}} , author={{ JShen } and { JWPan } and { ZXFan } and { XXXiong } and { RYZhan }} , journal={{J Neurosurg}} 119 , year={2013} } @incollection{b48, , title={{Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2)}} , author={{ RLMacdonald } and { RTHigashida } and { EKeller } and { SAMayer } and { AMolyneux } and { ARaabe }} , journal={{Acta Neurochir Suppl}} 115 , year={2013} } @incollection{b49, , title={{Nitric oxide-loaded echogenic liposomes for treatment of vasospasm following subarachnoid hemorrhage}} , author={{ HKim } and { GLBritton } and { TPeng } and { CKHolland } and { DDMcpherson } and { SLHuang }} , journal={{Int J Nanomedicine}} 9 , year={2014} } @incollection{b50, , title={{The role of nitric oxide donors in treating cerebral vasospasm after subarachnoid hemorrhage}} , author={{ ARFathi } and { KDBakhtian } and { RMPluta }} , journal={{Acta Neurochir Suppl}} 110 , year={2011} } @incollection{b51, , title={{Controlled release of a nitric oxide donor for the prevention of delayed cerebral vasospasm following experimental subarachnoid hemorrhage in nonhuman primates}} , author={{ REClatterbuck } and { PGailloud } and { TTierney } and { VMClatterbuck } and { KJMurphy } and { RJTamargo }} , journal={{J Neurosurg}} 103 , year={2005} } @incollection{b52, , title={{The role of the nitric oxide pathway in brain injury and its treatment -From bench to bedside}} , author={{ PSGarry } and { MEzra } and { MJRowland } and { JWestbrook } and { KtsPattinson }} , journal={{Experimental Neurology}} 263 , year={2015} } @incollection{b53, , title={{Acute decrease in cerebral nitric oxide levels after subarachnoid hemorrhage}} , author={{ FASehba } and { AYSchwartz } and { IChereshnev } and { JBBederson }} , journal={{J Cereb Blood Flow Metab}} 20 , year={2000} } @incollection{b54, , title={{Peroxynitrite, a stealthy biological oxidant}} , author={{ RRadi }} , journal={{J Biol Chem}} 288 , year={2013} } @incollection{b55, , title={{Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment}} , author={{ JMSimard } and { EFAldrich } and { DSchreibman } and { RFJames } and { APolifka } and { NBeaty }} , journal={{J Neurosurg}} 119 , year={2013} } @incollection{b56, , title={{Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a doubleblind, randomizedcomparison of enoxaparin versus placebo}} , author={{ GWurm } and { BTomancok } and { KNussbaumer } and { CAdelwöhrer } and { KHoll }} , journal={{Clin Neurol Neurosurq}} 106 , year={2004} } @incollection{b57, , title={{Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage}} , author={{ TYamamoto } and { TEsaki } and { YNakao } and { KMori }} , journal={{World Neurosurg}} 73 , year={2010} } @incollection{b58, , title={{Prospective, randomized, open-label phase II trial on concomitant intraventricular fibrinolysis and low-frequencyrotation after severe subarachnoid hemorrhage}} , author={{ NEtminan } and { KBeseoglu } and { SOEicker } and { BTurowski } and { HJSteiger } and { DHänggi }} , journal={{Stroke}} 44 , year={2013} }